Aerovate Therapeutics (AVTE) Stock Chart & Stock Price History $2.11 -0.03 (-1.40%) (As of 10/15/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Aerovate Therapeutics Stock Price Performance5 Day Performance+3.43%1 Month Performance+11.05%3 Month Performance+11.05%6 Month Performance-91.66%Year-To-Date Performance-90.68%1 Year Performance-80.82% Receive AVTE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyThe real reason Elon is fully endorsing TrumpElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. Watch this new documentary and you’ll discover what Elon knows, AVTE Stock Chart for Wednesday, October, 16, 2024 AVTE Chart by TradingView Aerovate Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/15/2024$2.14$2.11-1.40%$2.15$2.01150,798 shs$60.81 million10/14/2024$2.13$2.14+0.47%$2.16$2.0795,284 shs$61.68 million10/11/2024$2.04$2.13+4.41%$2.14$1.98848,242 shs$61.49 million10/10/2024$2.04$2.04$2.05$2.00142,386 shs$58.80 million10/09/2024$2.05$2.04-0.49%$2.06$2.01130,232 shs$58.80 million10/08/2024$2.08$2.05-1.44%$2.08$2.01100,834 shs$59.09 million Get the Latest News and Ratings for AVTE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/07/2024$2.05$2.08+1.46%$2.08$2.00239,744 shs$59.95 million10/04/2024$1.99$2.05+3.02%$2.06$1.99204,228 shs$59.09 million10/03/2024$2.07$1.99-3.86%$2.11$1.95168,943 shs$57.36 million10/02/2024$2.07$2.07$2.10$2.0390,273 shs$59.66 million10/01/2024$2.09$2.07-0.96%$2.13$1.98134,023 shs$59.66 million09/30/2024$2.06$2.09+1.46%$2.11$2.0375,987 shs$60.24 million09/27/2024$2.08$2.06-0.96%$2.11$2.05133,514 shs$59.47 million09/26/2024$1.97$2.08+5.58%$2.08$1.92154,109 shs$60.05 million09/25/2024$1.96$1.97+0.77%$1.99$1.92278,579 shs$56.87 million09/24/2024$1.89$1.96+3.44%$1.98$1.90338,685 shs$56.35 million09/23/2024$1.90$1.89-0.53%$1.92$1.84237,610 shs$54.47 million09/20/2024$1.98$1.90-4.04%$1.99$1.90500,918 shs$54.76 million09/19/2024$1.91$1.98+3.66%$2.00$1.88242,168 shs$57.07 million09/18/2024$1.91$1.91$2.00$1.88236,965 shs$55.05 million09/17/2024$1.91$1.91$1.96$1.88226,567 shs$55.05 million09/16/2024$1.90$1.91+0.53%$1.95$1.88159,216 shs$55.05 million09/13/2024$1.88$1.90+1.06%$1.97$1.89255,291 shs$54.85 million09/12/2024$1.92$1.88-2.08%$1.94$1.87149,317 shs$54.19 million09/11/2024$1.89$1.92+1.59%$1.94$1.85206,917 shs$55.34 million09/10/2024$1.92$1.89-1.56%$1.94$1.87157,848 shs$54.56 million09/09/2024$1.90$1.92+1.05%$1.96$1.86114,060 shs$55.43 million09/06/2024$1.94$1.90-2.06%$1.97$1.85170,654 shs$55.92 million09/05/2024$1.90$1.94+2.11%$1.94$1.86434,070 shs$55.92 million09/04/2024$1.86$1.90+2.15%$1.90$1.83163,699 shs$54.76 million09/03/2024$1.93$1.86-3.63%$1.97$1.83204,813 shs$53.61 million09/02/2024$1.93$1.93$1.93$1.82191,000 shs$55.63 million08/30/2024$1.85$1.93+4.32%$1.93$1.82183,704 shs$55.63 million08/29/2024$1.86$1.85-0.54%$1.91$1.84231,504 shs$53.32 million08/28/2024$1.88$1.86-1.06%$1.87$1.82165,232 shs$53.61 million08/27/2024$1.95$1.88-3.59%$1.95$1.85142,723 shs$54.19 million08/26/2024$1.87$1.95+4.28%$1.96$1.85434,545 shs$56.20 million08/23/2024$1.84$1.87+1.63%$1.91$1.83175,929 shs$53.90 million08/22/2024$1.88$1.84-2.13%$1.93$1.83132,257 shs$53.03 million08/21/2024$1.82$1.88+3.30%$1.89$1.83183,766 shs$54.19 millionMusk’s new company could top a trillion? (Ad)The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840. Click here to see the details because there’s not much time to prepare.08/20/2024$1.84$1.82-1.09%$1.86$1.7881,490 shs$52.46 million08/19/2024$1.78$1.84+3.37%$1.86$1.78185,874 shs$53.03 million08/16/2024$1.79$1.78-0.56%$1.83$1.73144,503 shs$51.30 million08/15/2024$1.72$1.79+4.07%$1.86$1.73142,802 shs$51.59 million08/14/2024$1.75$1.72-1.71%$1.76$1.6896,228 shs$49.57 million08/13/2024$1.72$1.75+1.74%$1.77$1.70204,643 shs$50.44 million08/12/2024$1.69$1.72+1.78%$1.73$1.65171,803 shs$49.57 million08/09/2024$1.70$1.69-0.59%$1.74$1.64354,450 shs$48.71 million08/08/2024$1.67$1.70+1.80%$1.71$1.63255,526 shs$49.00 million08/07/2024$1.64$1.67+1.83%$1.68$1.62391,087 shs$48.13 million08/06/2024$1.64$1.64$1.72$1.61406,760 shs$47.27 million08/05/2024$1.73$1.64-5.20%$1.71$1.61423,302 shs$47.27 million08/02/2024$1.79$1.73-3.35%$1.80$1.68287,017 shs$49.86 million08/01/2024$1.82$1.79-1.65%$1.84$1.76324,506 shs$51.59 million07/31/2024$1.82$1.82$1.92$1.78449,054 shs$52.46 million07/30/2024$1.89$1.82-3.70%$1.92$1.80610,599 shs$52.45 million07/29/2024$2.01$1.89-5.97%$2.02$1.88253,233 shs$54.47 million07/26/2024$1.92$2.01+4.69%$2.08$1.751.40 million shs$57.93 million07/25/2024$1.89$1.92+1.59%$1.97$1.86217,658 shs$55.33 million07/24/2024$1.80$1.89+5.29%$1.94$1.78364,123 shs$54.47 million07/23/2024$1.84$1.80-2.45%$1.89$1.79308,585 shs$51.73 million07/22/2024$1.78$1.84+3.37%$1.85$1.74390,795 shs$53.03 million07/19/2024$1.82$1.78-2.20%$1.88$1.77250,508 shs$51.30 million07/18/2024$1.89$1.82-3.70%$1.94$1.74434,755 shs$52.45 million07/17/2024$1.99$1.89-5.03%$1.99$1.89435,738 shs$54.47 million07/16/2024$1.90$1.99+4.74%$2.00$1.88473,406 shs$57.35 million07/15/2024$1.81$1.90+4.97%$1.90$1.80330,235 shs$54.76 million Related Companies: Leap Therapeutics Stock Chart CytomX Therapeutics Stock Chart Immunic Stock Chart Enanta Pharmaceuticals Stock Chart Inhibrx Stock Chart Gossamer Bio Stock Chart MacroGenics Stock Chart Adaptimmune Therapeutics Stock Chart Amylyx Pharmaceuticals Stock Chart SOPHiA GENETICS Stock Chart Receive AVTE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVTE) was last updated on 10/16/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk warns humanity: “Obsolete”The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredRetire off just one stock ticker?ONE AI Stock is All You Need... There are over 6,000 stocks listed in the market right now. They will NOT m...Behind the Markets | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredAI Detects Profit Surge On MondayThis has given investors the opportunity to beat the market by 1,700% and a 100% win rate to begin the year.Monument Traders Alliance | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aerovate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aerovate Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.